The article discusses the growing importance of genomics stocks in the market, highlighting BioMarin Pharmaceutical Inc. and the potential of the genomics industry. Cathie Wood emphasizes the revolutionary growth and potential of genomics, urging investors to consider these innovative stocks for long-term value.